Air ambulance market examination released
Visiongain has published a new Air Ambulance Market Report to 2031, which includes forecasts by service type, aircraft type and Covid-19 recovery scenarios
“Visiongain has anticipated the impact of Covid-19 lockdown on the market value of global leaders, followers, and disrupters,” said the company. “As lockdown has been executed differently across the world, the impact of the unplanned lockdown is also different in the countries. This report will help to develop strategies for companies by region/countries.”
Air medical market drivers are identified
The report states that the rising incidence and prevalence of cardiovascular diseases, osteoarthritis disorder, and multiple cancer require emergency medical response support to save lives are expected to be major driving factors for the growth of the air ambulance market during the forecast period. According to Cancer Australia estimates, around 1,405 new cases of brain cancer are expected in 2017. Furthermore, as per the World Health Organization (WHO), the common reason for death is cardiovascular diseases (CVD) across the world. Thereby, the rising high prevalence of cardiovascular diseases and other chronic disorders demands proper treatment management to maximize patient outcomes. In turn, it is projected to attain substantial growth for the air ambulance market in the given time frame.
The rapid increase in healthcare expenditure is also noted in the report as a key driver of growth for air medical operations: “Rising health expenditure per capita is accredited towards factors such as improving economic conditions in developing countries, greater access to competent emergency treatment. For instance, healthcare spending has increased drastically in the US in the past few decades. As per the Journal of the American Medical Association (JAMA), healthcare expenditure in the US upsurge near a trillion dollars between 1996 and 2015. The association told that healthcare expenditure in the U.S. during 2017 was around $3.5 trillion, i. e, $11,000 per person. These expenditures are projected to be $6 trillion –approximately $17,000 per person by 2027.”
Key air medical providers identified
The report states that key players operating in the global air ambulance market include Air Charter Service, Air Methods Corporation, Scandinavian Air Ambulance, AirMed International, Deccan Charters, Envision Healthcare Companies, Falck Danmark A/S, AMR Air Ambulance, Air Ambulance Specialists, and Express Aviation Services.
“The key players have adopted new product development, product launches, product approval, agreement, partnerships, and merger as its key business development strategies to tap into the global air ambulance market,” the report concluded.